Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 31, 2012
Peroxisome Proliferator-Activated Receptors (PPARs) As Molecular Targets For The Treatment And Prevention Of Diseases
Air date: Wednesday, March 11, 2009, 3:00:00 PM Category: Wednesday Afternoon Lectures
Description: Dr. Jeffrey Peters completed his graduate training at the University of California at Davis followed by postdoctoral fellowships at the Institute of Toxicology and Environmental Health at UC Davis, and then in the Laboratory of Metabolism at the National Cancer Institute. Dr. Peters has performed seminal research concerning the biological role of the PPAR class of nuclear receptors.
His more recent research has focused on elucidating functional roles of PPARb/d in disease. His research has had a profound impact on the risk assessment of a broad range of chemicals, helping to focus mechanistic research on the extrapolation of effects in animal models to humans. Additionally, his studies have provided clues to new molecular targets that may be suitable for the treatment and prevention of cancer.
Dr. Peters is a charter member of the Chemo/Dietary Prevention study section, he has served on a number of national committees, and he is on a variety of editorial boards in addition to serving as an Associate Editor for Toxicological Sciences. He has received a number of awards including the 2007 Society of Toxicology Achievement Award and the Black Award for Excellence in Research at Penn State.
The NIH Director's Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. Author: Jeffrey Peters Runtime: 00:56:04 Permanent link: http://videocast.nih.gov/launch.asp?1...